The tolerability of cisplatin with chemoradiotherapy in head and neck carcinoma
Ryutaro Uchi et al, 2019, JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY CrossRef
Modified 3-weekly cisplatin or cisplatin-5-fluorouracil 5-day infusion as the concurrent chemoradiotherapy regimen in locally advanced squamous cell carcinoma of the head and neck: Comparison of efficacy and toxicity
Yi-Fang Chang et al, 2020, Journal of Cancer Research and Practice CrossRef
Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer
Kuan-Chou Lin et al, 2021, Cancers CrossRef
Predicting the efficacy of chemoradiotherapy for locally advanced human papilloma virus-related oropharyngeal squamous cell carcinoma using one course of TPF chemotherapy
Takahito Kondo et al, 2021, European Archives of Oto-Rhino-Laryngology CrossRef
A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck Cancer
Dirk Rades et al, 2023, Journal of Personalized Medicine CrossRef
Incomplete cisplatin regimens in chemoradiation and its effect on outcomes for locally advanced cervical cancer
Nikhil V Kotha et al, 2022, International Journal of Gynecologic Cancer CrossRef
Efficacy and Safety of Cetuximab plus Radiotherapy in Cisplatin-Unfit Elderly Patients with Advanced Squamous Cell Head and Neck Carcinoma: A Retrospective Study
Raffaele Addeo et al, 2019, Chemotherapy CrossRef
Chemoradiotherapy with 3-weekly CDDP 80 mg/m2 for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 study
Kohei Otaki et al, 2022, Frontiers in Surgery CrossRef
Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
Rie Shimada et al, 2018, Japanese Clinical Medicine CrossRef
Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-Pacific
Ye Guo et al, 2024, Oral Oncology CrossRef